Project Oncology®

187 Folgen

1. Uncovering New Biomarkers for RCC: A Review of Emerging Techniques

   Vom: 30.7.2024
2. The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes

   Vom: 29.7.2024
3. Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool

   Vom: 23.7.2024
4. Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma

   Vom: 18.7.2024
5. Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

   Vom: 16.7.2024
6. Optimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer

   Vom: 16.7.2024
7. MCED Testing: Confirming a Positive Result with Diagnostic Follow-Up

   Vom: 11.7.2024
8. Current Updates in Brain Imaging and Neurodegenerative Diseases

   Vom: 9.7.2024
9. Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection

   Vom: 9.7.2024
10. Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis

    Vom: 3.7.2024
11. Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

    Vom: 2.7.2024
12. Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC

    Vom: 1.7.2024
13. A Look at the Utility of PSMA PET Scans in Prostate Cancer

    Vom: 1.7.2024
14. Highlighting the Current Status and Future of Theranostics

    Vom: 28.6.2024
15. The Evolving AI Landscape in Nuclear Medicine

    Vom: 28.6.2024
16. Diving into New Directions of Radiopharmaceuticals

    Vom: 28.6.2024
17. AI in Nuclear Medicine: Improvements in the Field

    Vom: 28.6.2024
18. A Look at the Horizon of Cancer Vaccines

    Vom: 20.6.2024
19. MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis

    Vom: 20.6.2024
20. A Unique Look at the Current and Future Directions of Cancer Vaccines

    Vom: 20.6.2024